These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 28772209)

  • 21. Renin-Angiotensin-aldosterone system and hypothalamic-pituitary-adrenal axis in hospitalized newborn foals.
    Dembek KA; Onasch K; Hurcombe SD; MacGillivray KC; Slovis NM; Barr BS; Reed SM; Toribio RE
    J Vet Intern Med; 2013; 27(2):331-8. PubMed ID: 23398197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): Focus on cardiovascular and neurological diseases.
    Mascolo A; Sessa M; Scavone C; De Angelis A; Vitale C; Berrino L; Rossi F; Rosano G; Capuano A
    Int J Cardiol; 2017 Jan; 227():734-742. PubMed ID: 27823897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the renin-angiotensin-aldosterone system for control of arterial blood pressure following moderate deficit in total body sodium: balance studies in freely moving dogs.
    Seeliger E; Lunenburg T; Ladwig M; Reinhardt HW
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e43-51. PubMed ID: 19930429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benchmarking renin suppression and blood pressure reduction of direct renin inhibitor imarikiren through quantitative systems pharmacology modeling.
    Gebremichael Y; Lahu G; Vakilynejad M; Hallow KM
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):15-25. PubMed ID: 30443840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAAS and stress markers in acute ischemic stroke: preliminary findings.
    Back C; Thiesen KL; Skovgaard K; Edvinsson L; Jensen LT; Larsen VA; Iversen HK
    Acta Neurol Scand; 2015 Feb; 131(2):132-9. PubMed ID: 25214428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrotic Roles of RAAS Blockers: Update.
    Zhang YY; Yu Y; Yu C
    Adv Exp Med Biol; 2019; 1165():671-691. PubMed ID: 31399990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases.
    De Mello WC
    Med Clin North Am; 2017 Jan; 101(1):117-127. PubMed ID: 27884223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F; Krzesinski JM; Piérard L; Scheen AJ
    Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The renin-angiotensin-aldosterone system: approaches to cardiac and renal therapy.
    Otte M; Spier A
    Compend Contin Educ Vet; 2009 Jan; 31(1):E1-7; quiz E7. PubMed ID: 19241351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renin angiotensin aldosterone system and insulin resistance in humans.
    Underwood PC; Adler GK
    Curr Hypertens Rep; 2013 Feb; 15(1):59-70. PubMed ID: 23242734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
    Ferrario CM; Strawn WB
    Am J Cardiol; 2006 Jul; 98(1):121-8. PubMed ID: 16784934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data.
    Black HR
    Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs.
    Martinez J; Kellogg C; Iazbik MC; Couto CG; Pressler BM; Hoepf TM; Radin MJ
    J Vet Intern Med; 2017 Jul; 31(4):988-993. PubMed ID: 28488321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
    Gromotowicz-Poplawska A; Szoka P; Kolodziejczyk P; Kramkowski K; Wojewodzka-Zelezniakowicz M; Chabielska E
    Exp Biol Med (Maywood); 2016 Nov; 241(17):1888-1899. PubMed ID: 27439538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.
    Patel BM; Mehta AA
    Eur J Pharmacol; 2012 Dec; 697(1-3):1-12. PubMed ID: 23041273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
    Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
    Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
    Turgut F; Balogun RA; Abdel-Rahman EM
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.